Loading Events
Find Webinars

Event Views Navigation

November 2018

“Management of Immune Checkpoint Inhibitor-related Toxicities”

November 12 @ 11:30 am - 12:30 pm

HealthTrust presents..."Management of Immune Checkpoint Inhibitor-related Toxicities" Pembrolizumab, nivolumab and other immune checkpoint inhibitors (ICPis) are currently FDA-approved for many different cancers and their indications for use continue to expand at a rapid rate. Despite the positive clinical benefits of these medications, however, there are many adverse effects associated with ICPis that are different than those of cytotoxic chemotherapy. The mechanism of action of ICPi agents can lead to toxicities in many body systems. Due to the need for guidance…

Find out more »

“USP <797>/<800>: Cleanroom Design & Environmental Monitoring”

November 14 @ 11:30 am - 12:30 pm

HealthTrust & TechSafety present..."USP <797>/<800>: Cleanroom Design & Environmental Monitoring" While USP (United States Pharmacopeia) <797> previously established requirements for hazardous drug compounding, its latest revision—<800>—clarifies and expands upon sterile and non-sterile hazardous drug compounding. Enhanced engineering and procedural controls extend protection to operators and environments when packaging, handling and compounding hazardous substances (including 2018 updates to the National Institute for Occupational Safety and Health list). Many sterile compounding pharmacies are unfamiliar with the certification requirements for their facilities and…

Find out more »
+ Export Events